
Silakan coba pencarian lain
YTD | 3Bln | 1T | 3Thn | 5T | 10T | |
---|---|---|---|---|---|---|
Pertumbuhan 1000 | 911 | 872 | 1004 | 1153 | 1523 | 2284 |
Imbal Hasil Dana | -8.93% | -12.77% | 0.37% | 4.86% | 8.78% | 8.61% |
Posisi di kategori | 370 | 323 | 340 | 302 | 236 | 184 |
% di kategori | 73 | 67 | 69 | 64 | 57 | 51 |
Nama | Peringkat | Total Aset | YTD% | 3T% | 10T% | |
---|---|---|---|---|---|---|
Bridge Builder Large Cap Growth | 26,85B | -6,18 | 10,92 | 12,47 | ||
Bridge Builder Large Cap Value | 23,48B | -2,30 | 8,43 | 9,80 | ||
Bridge Builder International Equity | 20,58B | 11,94 | 10,36 | - | ||
Bridge Builder Municipal Bond | 16,79B | -0,26 | 2,71 | - | ||
Bridge Builder Small/Mid Cap Value | 8,34B | -7,18 | 5,45 | 7,09 |
Nama | Peringkat | Total Aset | YTD% | 3T% | 10T% | |
---|---|---|---|---|---|---|
Principal MidCap Institutional | 15,63B | -0,94 | 12,51 | 11,67 | ||
Vanguard Mid-Cap Growth Index Admir | 12,48B | -1,77 | 8,87 | 9,64 | ||
T. Rowe Price Mid-Cap Growth I | 11,46B | -7,61 | 5,27 | - | ||
T. Rowe Price Mid-Cap Growth | 10,94B | -7,65 | 5,13 | 8,73 | ||
Janus Enterprise I | 8,61B | -5,25 | 8,08 | 11,03 |
Nama | ISIN | Bobot % | Terakhir | Perubahan % | |
---|---|---|---|---|---|
argenx ADR | US04016X1019 | 1,53 | 565,63 | +0,69% | |
Ascendis Pharma AS | US04351P1012 | 1,14 | 157,60 | +0,04% | |
Guidewire | US40171V1008 | 1,06 | 217,03 | +0,86% | |
Tradeweb Markets | US8926721064 | 1,04 | 145,17 | +1,16% | |
Axon Enterprise | US05464C1018 | 1,02 | 733,18 | +0,66% |
Jenis | Harian | Mingguan | Bulanan |
---|---|---|---|
Moving Average | Beli | Beli | Beli |
Indikator Teknikal | Sangat Beli | Sangat Beli | Sangat Beli |
Rangkuman | Sangat Beli | Sangat Beli | Sangat Beli |
Anda yakin ingin memblokir %USER_NAME%?
Jika ya, Anda dan %USER_NAME% tidak akan dapat melihat posting satu sama lain di Investing.com.
%USER_NAME% berhasil dimasukkan ke Daftar Blokir Anda
Karena Anda baru saja membatalkan blokir pengguna ini, Anda harus menunggu 48 jam sebelum kembali memblokir.
Menurut saya, komentar ini:
Terima Kasih!
Laporan Anda telah terkirim untuk ditinjau oleh moderator kami